Semaglutide | FDA Orange Book | Approved Drug Product List | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Semaglutide
FDA Orange Book

PharmaCompass Sponsored Ads

Contact Supplier

CCSB Semaglutide

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Semaglutide

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Semaglutide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

71 API Suppliers, 36 USDMF, 5 KDMF, 60 NDC API, 41 Listed Suppliers, $ API Reference Price

71 API Suppliers
36 USDMF
5 KDMF
60 NDC API
41 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

76 Drugs in Development

76 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

73 FDF Dossiers, 17 FDA Orange Book, 12 Europe, 11 Canada, 4 Australia, 2 South Africa, 27 Listed Dossiers

73 FDF Dossiers
17 FDA Orange Book
12 Europe
11 Canada
4 Australia
2 South Africa
27 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;SUBCUTANEOUS - 2MG/3ML (0.68MG/ML), SOLUTION;SUBCUTANEOUS - 2MG/1.5ML (1.34MG/ML), SOLUTION;SUBCUTANEOUS - 4MG/3ML (1.34MG/ML), SOLUTION;SUBCUTANEOUS - 8MG/3ML (2.68MG/ML)

SOLUTION;SUBCUTANEOUS - 2MG/3ML (0.68MG/ML)
SOLUTION;SUBCUTANEOUS - 2MG/1.5ML (1.34MG/ML)
SOLUTION;SUBCUTANEOUS - 4MG/3ML (1.34MG/ML)
SOLUTION;SUBCUTANEOUS - 8MG/3ML (2.68MG/ML)

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 1 BASF, 1 Finar, 1 Valens Pharmachem

1 Nanjing Well Pharmaceutical
1 BASF
1 Finar
1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

3 Topical, 2 Film Formers & Plasticizers, 2 Solubilizers, 1 Parenteral, 1 Emulsifying Agents, 1 Thickeners and Stabilizers

3 Topical
2 Film Formers & Plasticizers
2 Solubilizers
1 Parenteral
1 Emulsifying Agents
1 Thickeners and Stabilizers

DIGITAL CONTENT

8 DATA COMPILATION #PharmaFlow, 10 STOCK RECAP #PipelineProspector, 468 NEWS #PharmaBuzz

8 DATA COMPILATION #PharmaFlow
10 STOCK RECAP #PipelineProspector
468 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 12 Finished Drug Prices, 13 Annual Reports

1 US Medicaid Prescriptions
12 Finished Drug Prices
13 Annual Reports

MARKET PLACE

53 APIs, 6 FDF Dossiers

53 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

150 US Patents, 17 US Exclusivities

150 US Patents
17 US Exclusivities

$ API Ref.Price (USD/KG) : 582,160 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

17 All

01 15NOVO

02 2NOVO NORDISK INC

filter Dosage Reset all filters

17 All

01 9SOLUTION;SUBCUTANEOUS

02 8TABLET;ORAL

filter Regulatory Info Reset all filters

17 All

01 15RX

02 2Blank

filter Brand Name Reset all filters

17 All

01 4OZEMPIC

02 8RYBELSUS

03 5WEGOVY

filter RLD Reset all filters

17 All

01 15Yes

02 2Blank

Bachem Semaglutide

List of Suppliers

Product Main Page

01

NOVO

The Generic Rx Session

Not Confirmed

NOVO

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

SEMAGLUTIDE

Brand Name : OZEMPIC

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 2MG/1.5ML (1.34MG/ML)

Approval Date : 2017-12-05

Application Number : 209637

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

NOVO

PharmScience R&D

Not Confirmed

NOVO

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

SEMAGLUTIDE

Brand Name : OZEMPIC

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 4MG/3ML (1.34MG/ML)

Approval Date : 2019-04-09

Application Number : 209637

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

NOVO

PharmScience R&D

Not Confirmed

NOVO

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

SEMAGLUTIDE

Brand Name : OZEMPIC

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 8MG/3ML (2.68MG/ML)

Approval Date : 2022-03-28

Application Number : 209637

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

NOVO

PharmScience R&D

Not Confirmed

NOVO

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

SEMAGLUTIDE

Brand Name : OZEMPIC

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 2MG/3ML (0.68MG/ML)

Approval Date : 2022-10-06

Application Number : 209637

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

NOVO

PharmScience R&D

Not Confirmed

NOVO

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

SEMAGLUTIDE

Brand Name : RYBELSUS

Dosage Form : TABLET;ORAL

Dosage Strength : 3MG

Approval Date : 2019-09-20

Application Number : 213051

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

NOVO

PharmScience R&D

Not Confirmed

NOVO

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

SEMAGLUTIDE

Brand Name : RYBELSUS

Dosage Form : TABLET;ORAL

Dosage Strength : 7MG

Approval Date : 2019-09-20

Application Number : 213051

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

NOVO

PharmScience R&D

Not Confirmed

NOVO

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

SEMAGLUTIDE

Brand Name : RYBELSUS

Dosage Form : TABLET;ORAL

Dosage Strength : 14MG

Approval Date : 2019-09-20

Application Number : 213051

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

NOVO

PharmScience R&D

Not Confirmed

NOVO

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

SEMAGLUTIDE

Brand Name : RYBELSUS

Dosage Form : TABLET;ORAL

Dosage Strength : 1.5MG

Approval Date : 2024-12-09

Application Number : 213051

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

NOVO

PharmScience R&D

Not Confirmed

NOVO

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

SEMAGLUTIDE

Brand Name : RYBELSUS

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG

Approval Date : 2024-12-09

Application Number : 213051

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

NOVO

PharmScience R&D

Not Confirmed

NOVO

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

SEMAGLUTIDE

Brand Name : RYBELSUS

Dosage Form : TABLET;ORAL

Dosage Strength : 9MG

Approval Date : 2024-12-09

Application Number : 213051

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!